Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2025
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Release
Share
Press Release
Oct 31, 2021
| Rachel Schwartz
Biosimilars Council Encourages Stakeholders, Advocates to Join #GlobalBiosimilarsWeek
Press Release
Oct 27, 2021
| Rachel Schwartz
Kenneth Westberry Joins AAM As Senior Manager, State Government Affairs
Press Release
Oct 6, 2021
| Rachel Schwartz
Christine Simmon Named Executive Vice President, Policy and Strategic Alliances for the Association for Accessible Medicines
Press Release
Sep 21, 2021
| Rachel Schwartz
Study Finds U.S. Generic and Biosimilar Savings Totaled A Record $338 Billion in 2020
Press Release
Sep 13, 2021
| Rachel Schwartz
Polly Webster Joins AAM As Vice President, Federal Affairs
Press Release
Sep 13, 2021
| Rachel Schwartz
Scott Kuzner Joins AAM As Senior Director, Sciences and Regulatory Affairs
Press Release
Sep 9, 2021
| Rachel Schwartz
AAM Statement on HHS 45-Day Plan to Lower the Cost of Prescription Drugs
Press Release
Aug 16, 2021
| Rachel Schwartz
AAM Calls for Increased Voluntary Licensing of Covid Vaccines to Increase Patient Access
Press Release
Aug 12, 2021
| Rachel Schwartz
AAM Statement on President’s Build Back Better Plan
Press Release
Aug 10, 2021
| Rachel Schwartz
Joe Russo Joins AAM as Senior Director, Federal Government Affairs
Press Release
Jul 28, 2021
| Rachel Schwartz
Joanne Duncan Joins AAM as Chief Operating Officer
Press Release
Jul 19, 2021
| Rachel Schwartz
AAM Releases New Report: New Generics Are Less Available in Medicare Than Commercial Plans
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2025
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action